MedTrace Logo

Screening Protocol for the Evaluation of Research Participants at the Maryland Psychiatric Research Center (MPRC)

NCT01030835 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2017-07-02

No results posted yet for this study

Summary

Background:

\- The National Institute of Drug Abuse (NIDA) is interested in developing a pool of potential research participants who may be eligible for research studies on drug abuse and addiction, pharmacological and psychosocial therapies for substance addiction, drug abuse and co-occurring psychiatric disorders, and the long-term effects of drugs on the development, function, and structure of the brain and other organ systems. To develop this pool of potential participants, researchers intend to screen individuals who may be eligible for future research studies.

Objectives:

\- To identify, recruit, and screen participants for NIDA collaborative research protocols.

Eligibility:

\- Individuals 18 years of age and older who are able to provide informed consent.

Design:

* Eligible participants will undergo two screening interviews: a telephone interview and an in-person interview. The phone interview will determine eligibility for the in-person interview.
* The in-person interview, which may require up to five visits to the clinical center, will involve any or all of the following procedures: (1) full physical examination and medical history; (2) psychiatric interview; (3) psychological testing; (4) electrocardiogram; (5) samples of blood, urine, and hair; and (6) other minimally invasive procedures as directed by the research staff.
* Participants will provide a photograph for confirmation of identity for subsequent visits and protocols.
* No clinical care will be provided under this protocol.

Conditions

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • David A Gorelick, M.D. · National Institute on Drug Abuse (NIDA)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-05-28
Completion
2012-04-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01030835 on ClinicalTrials.gov